yes.
1. overheads is not going to reach 20mil pa. mixngo is already fully developed, producing it in large amts is easy. overheads shouldnt reach that amt.
2. mixngo is a disruptive technology (or at least we hope it to be, only 2 has signed up till now, when more coy signs it will only confirm this, but due to the nature of the bio-industry, signing up of deals takes time and we are at this stage.)
so if it is really a disruptive technology, i guess within the next 20years almost all diagnostic tools will be using mixngo
3. pe of 50 is too much when we get revenues streaming in.
when the coy is more established (ie in 2 years time), a pe of 10-20 will be reasonable. pe at this early stage is high due to the market rating the potential instead.
research more and ask more if you have further queries.
yes.1. overheads is not going to reach 20mil pa. mixngo is...
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.9¢ | 2.7¢ | $17.68K | 634.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 541015 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 4693635 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |